SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as retail investors and traders debate whether the stock is hitting a generational bottom or facing further decline following a sharp sell-off to 12-year lows. The conversation is dominated by divided sentiment, with some highlighting the brand's defensive 4% dividend yield as a value opportunity, while others point to weak consumer demand, intensifying competition, and lingering dissatisfaction with management's strategic direction as catalysts for continued downside.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as investors and social media users aggressively debate the company's financial performance and its deep association with the political brand of its namesake. Discussions are polarized between supporters highlighting the stock as a speculative opportunity and critics questioning the company's long-term business sustainability amid intense broader political volatility.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending as investors debate the impact of high short interest and anticipation for upcoming second-quarter earnings, while community sentiment remains split between bullish growth projections for its AI infrastructure projects and bearish concerns over potential dilution and transparency. Traders are actively monitoring for an official earnings announcement, with many looking for signs of execution on key regional milestones in Southeast Asia to validate the company's long-term revenue targets.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors react to a wave of ongoing litigation and strategic licensing deals, fueling speculation about potential settlements with memory industry leaders like Micron. Community members remain highly optimistic, citing the company's critical patent portfolio and anticipated expansion beyond the Samsung agreement, while continuing to debate the impact of potential Nasdaq uplisting and pending court catalysts.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as retail investors weigh the stock's significant decline against its attractive valuation and high insider accumulation. The community is actively debating the company's turnaround potential under incoming leadership, while some express frustration over perceived branding shifts and competitive pressures from peers like Alo and Vuori.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as the community reacts to the debut of its second-generation driverless truck fleet, fueling optimism about the company's path toward scaled commercialization. Investors are actively discussing the significance of upcoming earnings and potential new partnership announcements, with many pointing to long-term growth and supply-chain efficiency as key catalysts for sustained upside.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is currently trending following the recent FDA approval of KOMZIFTI, the first once-daily oral menin inhibitor for relapsed or refractory NPM1-mutated AML, which investors are positioning as a best-in-class treatment with a superior safety profile compared to competitors. The community is actively discussing the stock's significant long-term potential as it moves toward frontline trial expansion, while simultaneously tracking near-term catalysts like milestone payments and upcoming clinical data presentations at the ASH conference.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors react to a significant shift in capital allocation, highlighted by a move back to net equity buying and substantial stake increases in Alphabet. The community remains polarized, with some applauding the long-term compounding strategy under CEO Greg Abel, while others express frustration over stagnant price performance and a lack of dividends compared to broader market gains.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is currently drawing investor attention after delivering a strong earnings beat and raising revenue guidance, highlighting ongoing robust demand for its optical packaging and data center interconnect solutions. Despite the positive results, the stock is experiencing volatility as market participants debate its premium valuation and the impact of capital-intensive investments on free cash flow.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is capturing market interest as a key player in edge data center infrastructure, fueled by massive high-density GPU hosting contracts and a strategic pivot toward AI infrastructure. The community is actively discussing the company's ability to navigate data center supply chain bottlenecks, with investors closely monitoring potential growth catalysts and the scalability of its modular data center deployments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ATNM who  is buying ?
https://clinicaltrials.gov/study/NCT07422363

David Mcfadden

Mr.Yoda

johnny Anderson

Rick Rush

Anthonyisking

Clinicaltrials

ClinicalTrials.gov

StockTwits for iOS

Actinium Pharmaceuticals Inc

https://www.medchemexpress.com/cemiplimab.html?utm_source=google&amp;utm_medium=CPC&amp;utm_campaign=Inhibitory%20Antibodies&amp;utm_term=HY-P99203&amp;utm_content=REGN-2810&amp;gad_source=1&amp;gad_campaignid=23404384705&amp;gclid=Cj0KCQjwv4XUBhDBARIsAE6bQUT3ni_DNqdwynjSCoxmgdCgjielN2kSWCoAnpx4bVQoMf1D_uWnCmsaAghzEALw_wcB

Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research. - Mechanism of Action & Protocol.